Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer

J Exp Pathol. 1987 Summer;3(4):539-47.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cells, Cultured
  • Female
  • Humans
  • Immunity, Cellular
  • Interleukin-2 / pharmacology*
  • Leukocytes, Mononuclear / immunology*
  • Lymphocyte Activation*
  • Male
  • Middle Aged
  • Mitogens / pharmacology
  • Neoplasms / immunology*
  • Recombinant Proteins / pharmacology
  • T-Lymphocytes / immunology

Substances

  • Interleukin-2
  • Mitogens
  • Recombinant Proteins